Ascendis Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug.

CEO

Jan Møller Mikkelsen

CEOJan Møller Mikkelsen

Employees

—

Employees—

Headquarters

Hellerup, Capital Region

HeadquartersHellerup, Capital Region

Founded

2006

Founded2006

Employees

—

Employees—

ASND Key Statistics

Market cap

7.76B

Market cap7.76B

Price-Earnings ratio

-14.82

Price-Earnings ratio-14.82

Dividend yield

—

Dividend yield—

Average volume

308.36K

Average volume308.36K

High today

$142.36

High today$142.36

Low today

$135.16

Low today$135.16

Open price

$141.96

Open price$141.96

Volume

511.41K

Volume511.41K

52 Week high

$161.00

52 Week high$161.00

52 Week low

$83.75

52 Week low$83.75

ASND News

Yahoo Finance 1d

Ascendis Pharma First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Ascendis Pharma (NASDAQ:ASND) First Quarter 2024 Results Key Financial Results Revenue: €95.9m (up 186% from 1Q 2023). Net loss: €131.0m (loss widened by 18%...

TipRanks 3d

Ascendis Pharma Posts Q1 Revenue Growth Amid Losses - TipRanks.com - TipRanks

Ascendis Pharma A/S (ASND) has released an update. Ascendis Pharma A/S, a biopharmaceutical company, reported increased revenue of EUR 95,894,000 for the first...

Analyst ratings

85%

of 13 ratings

Buy

84.6%

Hold

15.4%

Sell